ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.18
      0.28%
      US Tech 100
      19,874.00
      0.41%
      Dow Jones
      40,167.32
      0.42%
      Brent Oil
      84.31
      -0.34%
      Bitcoin
      63,344.52
      4.22%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      10/01/20206:01AMPR Newswire (Canada)SKYRIZI®, commercialisé par AbbVie, est maintenant remboursé par d'autres régimes publics d'assurance médicaments pour l...NYSE:ABBVAbbVie Inc
      10/01/20206:01AMPR Newswire (Canada)Public coverage of AbbVie's SKYRIZI® for the treatment of Moderate to Severe Plaque Psoriasis is now available across additi...NYSE:ABBVAbbVie Inc
      09/30/20208:45AMInvestorWireSolving One of the Largest Drivers of Disease: InflammationNYSE:ABBVAbbVie Inc
      09/28/20209:29AMDow Jones NewsAbbVie Gets Orphan Drug Designation for Spinal Cord Injury TreatmentNYSE:ABBVAbbVie Inc
      09/28/20208:00AMPR Newswire (US)AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investi...NYSE:ABBVAbbVie Inc
      09/16/20208:00AMPR Newswire (US)Malin Akerman Joins CoolSculpting® and CoolTone™ as U.S. Ambassador for the Allergan Aesthetics Body Contouring PortfolioNYSE:ABBVAbbVie Inc
      09/14/20208:00AMPR Newswire (US)Allergan Aesthetics and Skinbetter Science Announce The DREAM Initiative™ To Advance Health Equity and Diversity in Aesthet...NYSE:ABBVAbbVie Inc
      09/11/202011:30AMPR Newswire (US)AbbVie to Present New Data From 18 Abstracts at the International Congress of Parkinson's Disease and Movement Disorders®NYSE:ABBVAbbVie Inc
      09/11/20209:39AMPR Newswire (US)AbbVie Declares Quarterly DividendNYSE:ABBVAbbVie Inc
      09/04/20208:02AMDow Jones NewsI-Mab, AbbVie to Collaborate on Cancer Treatment LemzoparlimabNYSE:ABBVAbbVie Inc
      09/04/20207:00AMPR Newswire (US)AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology TherapyNYSE:ABBVAbbVie Inc
      09/03/20208:00AMPR Newswire (US)AbbVie to Present at the Morgan Stanley Healthcare ConferenceNYSE:ABBVAbbVie Inc
      08/25/202010:24AMDow Jones NewsAbbVie Seeks FDA OK for Rinvoq in Adults With Active Ankylosing SpondylitisNYSE:ABBVAbbVie Inc
      08/25/20208:47AMDow Jones NewsAbbVie, Harvard Target Emergent Viral Diseases in $30 Million CollaborationNYSE:ABBVAbbVie Inc
      08/25/20208:45AMPR Newswire (US)AbbVie Submits Regulatory Application to FDA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Ankylosing ...NYSE:ABBVAbbVie Inc
      08/25/20208:00AMPR Newswire (US)AbbVie, Harvard University Form Research Alliance to Address Emergent Viral DiseasesNYSE:ABBVAbbVie Inc
      08/25/20207:29AMDow Jones NewsMorphic to Get $20 Million as AbbVie Exercises License OptionNYSE:ABBVAbbVie Inc
      08/25/20206:30AMGlobeNewswire Inc.Morphic Announces that AbbVie Exercises License Option to αvβ6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic...NYSE:ABBVAbbVie Inc
      08/12/20205:45PMPR Newswire (US)New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Pat...NYSE:ABBVAbbVie Inc
      08/04/20201:26PMDow Jones NewsVoyager Therapeutics Down 11% on End of AbbVie CollaborationsNYSE:ABBVAbbVie Inc
      08/04/20209:57AMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:ABBVAbbVie Inc
      08/03/20207:21PMDow Jones NewsVoyager Therapeutics Down 15% on End of AbbVie CollaborationsNYSE:ABBVAbbVie Inc
      08/03/20207:30AMPR Newswire (US)Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID TrialNYSE:ABBVAbbVie Inc
      07/31/20208:43AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      07/31/20208:32AMDow Jones NewsAbbVie Reports 2Q Loss, Allergan-Deal Cost Hurt Bottom LineNYSE:ABBVAbbVie Inc
      07/31/20207:43AMPR Newswire (US)AbbVie Reports Second-Quarter 2020 Financial ResultsNYSE:ABBVAbbVie Inc
      07/29/20204:58PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      07/29/20208:45AMPR Newswire (US)AbbVie Announces Positive Phase 3 Data for Atogepant in Migraine PreventionNYSE:ABBVAbbVie Inc
      07/28/20206:58PMDow Jones NewsCorrection to AbbVie Skin-Treatment ArticleNYSE:ABBVAbbVie Inc
      07/28/20209:29AMDow Jones NewsAbbVie Skin Treatment Successful in Phase 3 TrialNYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV